Degradation of ginsenosides in humans after oral administration
about
Ginsenosides from American ginseng: chemical and pharmacological diversityProtective effects of ginseng on neurological disordersComparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound KIn Silico and In Vitro Analysis of Bacoside A Aglycones and Its Derivatives as the Constituents Responsible for the Cognitive Effects of Bacopa monnieriDammarane Sapogenins Ameliorates Neurocognitive Functional Impairment Induced by Simulated Long-Duration Spaceflight.Metabolite 1 of protopanaxadiol-type saponins, an axonal regenerative factor, stimulates teneurin-2 linked by PI3-kinase cascade.Mass spectrometric imaging of ginsenosides localization in Panax ginseng root.Determination of 20(S)-ginsenoside Rh1 and its aglycone 20(S)-protopanaxatriol in rat plasma by sensitive LC-APCI-MS method and its application to pharmacokinetic study.Effect of sugar positions in ginsenosides and their inhibitory potency on Na+/K+-ATPase activity.Active ingredients in Chinese medicines promoting blood circulation as Na+/K+ -ATPase inhibitors.Comparative analysis of the expression level of recombinant ginsenoside-transforming β-glucosidase in GRAS hosts and mass production of the ginsenoside Rh2-MixIdentification and characterization of a novel Terrabacter ginsenosidimutans sp. nov. beta-glucosidase that transforms ginsenoside Rb1 into the rare gypenosides XVII and LXXV.Simultaneous determination of three major bioactive saponins of Panax notoginseng using liquid chromatography-tandem mass spectrometry and a pharmacokinetic study.Hormetic Property of Ginseng Steroids on Anti-Oxidant Status against Exercise Challenge in Rat Skeletal Muscle.Identification and characterization of the Rhizobium sp. strain GIN611 glycoside oxidoreductase resulting in the deglycosylation of ginsenosides.Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics.Biotransformation of ginsenoside Rb1 via the gypenoside pathway by human gut bacteriaEffect of a soluble prebiotic fiber, NUTRIOSE, on the absorption of ginsenoside Rd in rats orally administered ginseng.Isolation and analysis of ginseng: advances and challenges.American ginseng attenuates azoxymethane/dextran sodium sulfate-induced colon carcinogenesis in mice.Effect of ginseng and ginsenosides on melanogenesis and their mechanism of action.The effectiveness of borneol on pharmacokinetics changes of four ginsenosides in Shexiang Baoxin Pill in vivo.Ginseng and ginsenoside Re do not improve β-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetesProtopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer.Ginseng derivative ocotillol enhances neuronal activity through increased glutamate release: a possible mechanism underlying increased spontaneous locomotor activity of mice.Effect of Fermented Red Ginseng Extract Enriched in Ginsenoside Rg3 on the Differentiation and Mineralization of Preosteoblastic MC3T3-E1 Cells.Ultra-performance liquid chromatography and time-of-flight mass spectrometry analysis of ginsenoside metabolites in human plasmaA prebiotic fiber increases the formation and subsequent absorption of compound K following oral administration of ginseng in ratsColon cancer chemopreventive effects of baicalein, an active enteric microbiome metabolite from baicalinGinsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action.Ginsenoside Re: Its chemistry, metabolism and pharmacokineticsAmerican ginseng significantly reduced the progression of high-fat-diet-enhanced colon carcinogenesis in Apc (Min/+) micePreparation of minor ginsenosides C-Mc, C-Y, F2, and C-K from American ginseng PPD-ginsenoside using special ginsenosidase type-I from Aspergillus niger g.848.Phytochemistry and Anticancer Potential of Notoginseng.Pharmacokinetics of a multicomponent herbal preparation in healthy Chinese and African volunteers.Bioactivity enhancement of herbal supplements by intestinal microbiota focusing on ginsenosidesSimultaneous determination of ginsenoside Rg1 , Re and notoginsenoside R1 in human plasma by LC-MS/MS and its application in a pharmacokinetic study in Chinese volunteers.Inhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microflora.Development and validation of an UPLC-Q/TOF-MS assay for the quantitation of neopanaxadiol in beagle dog plasma: Application to a pharmacokinetic study.Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.
P2860
Q24630142-6CA34C91-D91D-4332-8A22-2EF08A5BEAE3Q26800067-9C0021F1-61B3-4354-93ED-5C3C5B6C11F9Q28487235-8ED8F36E-95BF-4DD1-9DEF-9058507C18A0Q28547187-19E80058-BDED-4799-8D5A-F1474F8D7B66Q30853766-D652F4FF-7207-45C3-9CD5-F7D333E64090Q33227341-F8C7A957-266C-424E-99F0-EA78D5D3C3A4Q33349138-DBFCE91C-77C1-4243-9272-DE23EEC4DCBFQ33441874-5DF59602-F2C6-4214-ACFB-C840A28D3B91Q33552185-C853EE05-838E-47A8-8B76-AB8ED618B542Q33565693-2940FB88-D6A0-48F2-9583-F437195EF5E9Q33579703-888B865D-3E15-4CE3-A4FC-C762FDF8ABB8Q33630182-F84FF49F-8103-459B-B42F-6BF432E691CEQ33766042-58D9969C-FB57-4023-ADA3-6DDCE4544938Q33845058-AEC34141-9CAA-4B95-A6DA-CF5A54CDF132Q34054700-4810DBFB-E8BA-4979-8786-23EA63451087Q34243995-4B479320-56C0-41D9-BEA8-AFEC3F4E097CQ34245916-3071B5B2-7245-49FC-9928-B5618E235E35Q34424688-150ABFBD-1384-464B-8552-3909530C013EQ34667126-32614082-22D1-4AC4-ACD3-0A4A56CDC9B3Q34719242-FB5846C8-E7E4-411D-BFA3-A706692CE876Q34719282-58075D14-45E5-43E6-8AB7-4BD4E80B4A75Q35016625-A949314C-2104-4139-92D9-1A8AE95EBFDDQ35043848-35218ACC-8C1D-4697-B00E-69B9076298A7Q35131299-F6710A82-1537-468B-BE54-A56ED74BDBECQ35353349-1ABA35B4-1E05-48C5-9DF9-FEF30AE9CEC5Q35540865-30A10F5C-1D06-4CA1-9C78-23A2A3EF2709Q35634469-E1EF372C-7658-49C4-9667-B06DF2A55D78Q35675156-8FC036FB-D2B3-4C14-90DF-FEFDBF0F7F35Q35785294-C16E1A81-FB58-465F-8B8A-A4CA76D2BDC1Q35787329-B5F4F5C2-5D8B-4D52-A8D5-DC5D4F41FAC8Q35811907-379FC9AD-A3D5-4BE0-BAAC-B3A4C1CC9B66Q35863092-F2A31A0A-EAB8-4CF8-A781-38457C09C2F4Q35863117-9FF948F9-0B08-46DD-A3E4-9B30F102C144Q35936407-C6BE0146-CE89-42BD-833E-4B2AC14E8447Q35947889-05BDABDF-1356-4607-9C11-D7513A87B055Q35950044-9E840137-8032-426D-97F1-99B9624827A4Q36027918-A6013622-8DA3-4400-9B98-4B878DEFF2D6Q36105337-64D8764D-A7F1-4D0C-A0AB-E103B521CC43Q36176846-7A542F76-4F93-4ECB-9BF3-DDDCA6856F34Q36252847-142C9CED-EBCB-43BB-8CD2-D047DE64E42F
P2860
Degradation of ginsenosides in humans after oral administration
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Degradation of ginsenosides in humans after oral administration
@ast
Degradation of ginsenosides in humans after oral administration
@en
Degradation of ginsenosides in humans after oral administration
@nl
type
label
Degradation of ginsenosides in humans after oral administration
@ast
Degradation of ginsenosides in humans after oral administration
@en
Degradation of ginsenosides in humans after oral administration
@nl
prefLabel
Degradation of ginsenosides in humans after oral administration
@ast
Degradation of ginsenosides in humans after oral administration
@en
Degradation of ginsenosides in humans after oral administration
@nl
P2093
P3181
P356
P1476
Degradation of ginsenosides in humans after oral administration
@en
P2093
Mario Wurglics
Michael Karas
Mona Abdel Tawab
P304
P3181
P356
10.1124/DMD.31.8.1065
P407
P577
2003-08-01T00:00:00Z